Characterizing the Cross-sectional Approach to Investigate the Prevalence of Tissue BRCA1/2 Mutations in Newly Diagnosed Advanced Ovarian Cancer Patients
Clinical trial NCT04222465 · COMPLETED
Trial details
- NCT number
- NCT04222465
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-03-19
- Primary completion
- 2020-11-13
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.